MiR-146a was also upregulated in AD, and miR-146a adjustment was shown to improve cognitive impairment and alleviate the entire pathological processes, including tau phosphorylation, in APP/PS1 transgenic mice, a mouse model of AD [78]. The gene discussed is MAPT; the disease is Alzheimer disease.